404 related articles for article (PubMed ID: 19178144)
1. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis.
Jiang G; Park K; Kim J; Kim KS; Hahn SK
Mol Pharm; 2009; 6(3):727-37. PubMed ID: 19178144
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA.
Jiang G; Park K; Kim J; Kim KS; Oh EJ; Kang H; Han SE; Oh YK; Park TG; Kwang Hahn S
Biopolymers; 2008 Jul; 89(7):635-42. PubMed ID: 18322932
[TBL] [Abstract][Full Text] [Related]
3. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate.
Park K; Lee MY; Kim KS; Hahn SK
Biomaterials; 2010 Jul; 31(19):5258-65. PubMed ID: 20378167
[TBL] [Abstract][Full Text] [Related]
4. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex.
Lee MY; Park SJ; Park K; Kim KS; Lee H; Hahn SK
ACS Nano; 2011 Aug; 5(8):6138-47. PubMed ID: 21739990
[TBL] [Abstract][Full Text] [Related]
5. Target specific systemic delivery of TGF-β siRNA/(PEI-SS)-g-HA complex for the treatment of liver cirrhosis.
Park K; Hong SW; Hur W; Lee MY; Yang JA; Kim SW; Yoon SK; Hahn SK
Biomaterials; 2011 Jul; 32(21):4951-8. PubMed ID: 21481451
[TBL] [Abstract][Full Text] [Related]
6. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
[TBL] [Abstract][Full Text] [Related]
7. LHRH receptor-mediated delivery of siRNA using polyelectrolyte complex micelles self-assembled from siRNA-PEG-LHRH conjugate and PEI.
Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
Bioconjug Chem; 2008 Nov; 19(11):2156-62. PubMed ID: 18850733
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate.
Kim SH; Mok H; Jeong JH; Kim SW; Park TG
Bioconjug Chem; 2006; 17(1):241-4. PubMed ID: 16417275
[TBL] [Abstract][Full Text] [Related]
9. A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery.
Shen Y; Wang B; Lu Y; Ouahab A; Li Q; Tu J
Int J Pharm; 2011 Jul; 414(1-2):233-43. PubMed ID: 21545832
[TBL] [Abstract][Full Text] [Related]
10. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels.
Lee H; Mok H; Lee S; Oh YK; Park TG
J Control Release; 2007 Jun; 119(2):245-52. PubMed ID: 17408798
[TBL] [Abstract][Full Text] [Related]
11. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.
Alshamsan A; Hamdy S; Samuel J; El-Kadi AO; Lavasanifar A; Uludağ H
Biomaterials; 2010 Feb; 31(6):1420-8. PubMed ID: 19913908
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer cell-specific VEGF siRNA delivery system using cell targeting peptide conjugated polyplexes.
Kim SH; Lee SH; Tian H; Chen X; Park TG
J Drug Target; 2009 May; 17(4):311-7. PubMed ID: 19242850
[TBL] [Abstract][Full Text] [Related]
13. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A
J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264
[TBL] [Abstract][Full Text] [Related]
14. Intracellular trafficking and unpacking of siRNA/quantum dot-PEI complexes modified with and without cell penetrating peptide: confocal and flow cytometric FRET analysis.
Lee H; Kim IK; Park TG
Bioconjug Chem; 2010 Feb; 21(2):289-95. PubMed ID: 20078095
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression.
Huang HY; Kuo WT; Chou MJ; Huang YY
J Biomed Mater Res A; 2011 Jun; 97(3):330-8. PubMed ID: 21465641
[TBL] [Abstract][Full Text] [Related]
16. Bioimaging for targeted delivery of hyaluronic Acid derivatives to the livers in cirrhotic mice using quantum dots.
Kim KS; Hur W; Park SJ; Hong SW; Choi JE; Goh EJ; Yoon SK; Hahn SK
ACS Nano; 2010 Jun; 4(6):3005-14. PubMed ID: 20518553
[TBL] [Abstract][Full Text] [Related]
17. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine).
Hwa Kim S; Hoon Jeong J; Chul Cho K; Wan Kim S; Gwan Park T
J Control Release; 2005 May; 104(1):223-32. PubMed ID: 15866348
[TBL] [Abstract][Full Text] [Related]
18. [Silence of VEGFR2 expression mediated by PEI/siRNA complexes].
Yang H; Che O; Chen S; Sun L; Ji AM
Yao Xue Xue Bao; 2010 May; 45(5):576-81. PubMed ID: 20931758
[TBL] [Abstract][Full Text] [Related]
19. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy.
Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
J Control Release; 2006 Nov; 116(2):123-9. PubMed ID: 16831481
[TBL] [Abstract][Full Text] [Related]
20. Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity.
Zintchenko A; Philipp A; Dehshahri A; Wagner E
Bioconjug Chem; 2008 Jul; 19(7):1448-55. PubMed ID: 18553894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
